valproic acid and histamine

valproic acid has been researched along with histamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, Z; Fujii, Y; Ishizawa, K; Kamei, C; Okuma, C; Sugimoto, Y1
Kato, N; Kato, T; Kazuno, AA; Munakata, K1
Barreto-Vizcaíno, S; Garcia-Solorzano, A; Isais-Millán, R; López-Blanca, C; Membrila-Maldonado, M; Millán-Guerrero, RO; Muñoz-Solis, R; Rivera-Castaño, L1
Baronio, D; Lehtonen, E; Panula, P; Puttonen, HAJ; Semenova, S; Sundvik, M1
Esmaeilpour, K; Sepehri, G; Sheibani, V; Shekari, MA; Taheri, F1

Trials

1 trial(s) available for valproic acid and histamine

ArticleYear
Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study.
    European journal of neurology, 2007, Volume: 14, Issue:10

    Topics: Adolescent; Adult; Double-Blind Method; Female; Histamine; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Valproic Acid

2007

Other Studies

7 other study(ies) available for valproic acid and histamine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Participation of GABAergic and histaminergic systems in inhibiting amygdaloid kindled seizures.
    Japanese journal of pharmacology, 2000, Volume: 82, Issue:1

    Topics: Amygdala; Animals; Bicuculline; Diazepam; gamma-Aminobutyric Acid; Histamine; Imidazoles; Kindling, Neurologic; Male; Muscimol; Rats; Rats, Wistar; Seizures; Thiourea; Valproic Acid

2000
Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids.
    The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:1

    Topics: Adult; Antimanic Agents; Calcium; Calcium Signaling; Cell Line; Cell Nucleus; DNA, Mitochondrial; Female; Histamine; Humans; Hybrid Cells; Lithium Chloride; Male; Mitochondria; Valproic Acid

2008
Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio).
    British journal of pharmacology, 2018, Volume: 175, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Dopamine beta-Hydroxylase; Histamine; Histidine Decarboxylase; Larva; Locomotion; Male; Neurons; Norepinephrine; Receptors, Histamine; Social Behavior; Tyrosine 3-Monooxygenase; Valproic Acid; Zebrafish

2018
Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
    Behavioural pharmacology, 2023, 06-01, Volume: 34, Issue:4

    Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Cognition; Cognitive Dysfunction; Disease Models, Animal; Female; Histamine; Histamine H3 Antagonists; Humans; Prenatal Exposure Delayed Effects; Rats; Social Behavior; Valproic Acid

2023